---
title: "MIRZA NADEEM Q. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ff0ecbfa-3a52-514d-8359-ff0c29849cf2
json: https://whiteintel.dev/api/public/dossier/ff0ecbfa-3a52-514d-8359-ff0c29849cf2
identifier: sec:0002021015
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MIRZA NADEEM Q.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002021015`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ff0ecbfa-3a52-514d-8359-ff0c29849cf2  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ff0ecbfa-3a52-514d-8359-ff0c29849cf2  

## Ownership & control

### Holdings / subsidiaries

- **Aprea Therapeutics, Inc.** (officer) — https://whiteintel.dev/entity/4a07e81e-7894-5160-afdf-6de06bddeb11

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MIRZA NADEEM Q.**. Human view: https://whiteintel.dev/entity/ff0ecbfa-3a52-514d-8359-ff0c29849cf2 · Structured JSON: https://whiteintel.dev/api/public/dossier/ff0ecbfa-3a52-514d-8359-ff0c29849cf2._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._